4.7 Article

Gut microbiota induces DNA methylation via SCFAs predisposing obesity-prone individuals to diabetes

Journal

PHARMACOLOGICAL RESEARCH
Volume 182, Issue -, Pages -

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2022.106355

Keywords

Obesity-prone; DNA methylation; Gut microbiota; SCFAs; Propionate; DAB1

Funding

  1. National Natural Science Foundation of China [81803970, 81973714]
  2. Young Talent Promotion Project of China Association of Chinese Medicine [CACM-2019-QNRC2-A01]
  3. Young Scientists Development Program of Beijing University of Chinese Medicine
  4. Fundamental Research Funds for the Central Universities [2020-JYB-XJSJJ-003]
  5. Beijing University of Chinese Medicine High-level Talent Research Start-up Fund Project

Ask authors/readers for more resources

This study revealed that obesity-prone individuals show diabetes-related DNA methylation signatures even when they have normal weight and BMI. The gut microbiota and microbial-derived short-chain fatty acids (SCFAs) were found to play a significant role in inducing DNA methylation and predisposing individuals to diabetes.
Obesity-prone (OP) individuals have a significant predisposition to obesity and diabetes. Previously, we have found that OP individuals, despite being normal in weight and BMI, have already exhibited diabetes-related DNA methylation signatures. However, the underlying mechanisms remain obscure. Here we determined the effects of gut microbiota on DNA methylation and investigated the underlying mechanism from microbial-derived short-chain fatty acids (SCFAs). Diabetes-related DNA methylation loci were screened and validated in a new OP cohort. Moreover, the OP group was revealed to have distinct gut microbiota compositions, and fecal microbiota transplantation (FMT) demonstrated the role of gut microbiota in inducing diabetes-related DNA methylations and glucolipid disorders. UPLC-ESI-MS/MS analysis indicated a significantly lower level of total fecal SCFAs in the OP group. The gut microbiota from OP subjects yielded markedly decreased total SCFAs, while notably enriched propionate. Additionally, propionate was also identified by variable importance in projection (VIP) score as the most symbolic SCFAs of the OP group. Further cellular experiments verified that propionate could induce hypermethylation at locus cg26345888 and subsequently inhibit the expression of the target gene DAB1, which was crucially associated with clinical vitamin D deficiency and thus may affect the development and progression of diabetes. In conclusion, our study revealed that gut microbiota-derived propionate induces specific DNA methylation, thus predisposing OP individuals to diabetes. The findings partially illuminate the mechanisms of diabetes susceptibility in OP populations, implying gut microbiota and SCFAs may serve as promising targets both for clinical treatment and medication development of diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available